ZOLEDRONIC ACID INCREASES THE IN VITRO APOPTOTIC EFFECT OF BORTEZOMIB AND MAY OVERCOME DRUG RESISTANCE IN HUMAN MYELOMA CELLS

被引：0
|
作者：
Colla, S. [1 ]
Bonomini, S. [1 ]
Lunghi, P. [2 ]
Bonati, A. [1 ,2 ]
Rizzoli, V [1 ]
Giuliani, N. [1 ]
机构：
[1] Univ Parma, Ematol & CTMO, Parma, Italy
[2] Univ Parma, Dipartimento Sci Clin, Parma, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C029
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
    Tassone, P
    Tagliaferri, P
    Viscomi, C
    Palmieri, C
    Caraglia, M
    D'Alessandro, A
    Galea, E
    Goel, A
    Abbruzzese, A
    Boland, CR
    Venuta, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (12) : 1971 - 1978
  • [2] Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
    P Tassone
    P Tagliaferri
    C Viscomi
    C Palmieri
    M Caraglia
    A D'Alessandro
    E Galea
    A Goel
    A Abbruzzese
    C R Boland
    S Venuta
    [J]. British Journal of Cancer, 2003, 88 : 1971 - 1978
  • [3] The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide
    Abeltino, Manuela
    Bonomini, Sabrina
    Bolzoni, Marina
    Storti, Paola
    Colla, Simona
    Todoerti, Katia
    Agnelli, Luca
    Neri, Antonino
    Rizzoli, Vittorio
    Giuliani, Nicola
    [J]. EXPERIMENTAL HEMATOLOGY, 2011, 39 (01) : 55 - 65
  • [4] Macrolides overcome cell adhesion-mediated bortezomib resistance and enhance the cytotoxic effect in myeloma cells
    Moriya, Shota
    Kazama, Hiromi
    Hiramoto, Masaki
    Miyazawa, Keisuke
    [J]. CANCER SCIENCE, 2018, 109 : 891 - 891
  • [5] Targeting mitochondria to overcome conventional and Bortezomib-resistance in multiple myeloma cells.
    Chauhan, D
    Li, GL
    Podar, K
    Hideshima, T
    Nicholas, M
    Constatntine, M
    Catley, L
    Munshi, N
    Anderson, KC
    [J]. BLOOD, 2003, 102 (11) : 189A - 189A
  • [6] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
    Hideshima, T
    Chauhan, D
    Shima, Y
    Raje, N
    Davies, FE
    Tai, YT
    Treon, SP
    Lin, B
    Schlossman, RL
    Richardson, P
    Muller, G
    Stirling, DI
    Anderson, KC
    [J]. BLOOD, 2000, 96 (09) : 2943 - 2950
  • [7] Cytotoxic and Apoptotic Effects of Pinostilbene and Bortezomib Combination Treatment on Human Multiple Myeloma Cells
    Staskiewicz, Anna
    Wong, Erica
    Tucker, Michael
    Farhin, Riya
    Park, Jonathan
    Saade, Rana
    Alkhazali, Tina
    Dang, Tu
    Wang, Xinyu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [8] Inhibition of apoptosis may lead to the development of bortezomib resistance in multiple myeloma cancer cells
    Oksuzoglu, Emine
    Kozalak, Gul
    [J]. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2021, 46 (01): : 63 - 69
  • [9] Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells
    Heino, Terhi J.
    Alm, Jessica J.
    Halkosaari, Heikki J.
    Valimaki, Ville-Valtteri
    [J]. ACTA ORTHOPAEDICA, 2016, 87 (04) : 412 - 417
  • [10] BORTEZOMIB-BASED TREATMENT MAY OVERCOME THE ADVERSE EFFECT OF FOPNL GENOMIC VARIANT ON THE PROGNOSIS OF MULTIPLE MYELOMA
    Kiss, K. P.
    Varga, G.
    Mikala, G.
    Bors, A.
    Balassa, K.
    Tordai, A.
    Remenyi, P.
    Masszi, T.
    Andrikovics, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 528 - 528
12345